RBBP4 and non-small cell lung carcinoma: miR-145 can significantly reduce RBBP4 promoter activity, mRNA and protein levels, and hsa_circ_0102231 can promote NSCLC proliferation and invasion by reversing the anti-tumor effects of miR-145 through the miR-145/RBBP4 axis (29).